New Digital Imaging Technologies

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...

March 13, 2018 at 4pm GMT Register for this webinar: Click here Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure...

A pair of recently developed AI systems can diagnose lung cancer and heart disease more accurately than human doctors. These AIs have the potential to save billions of dollars and countless lives if widely adopted. Improved...

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial...

Largest digital pathology study to date, analyzing and validating over 6600 FFPE slides, yields an approval for the use of OptraSCAN® whole slide scanners in India medical settings SUNNYVALE, CA--(BUSINESS WIRE)—OptraSCAN today announced...

NHS Trust Plymouth Hospitals, Derriford Hospital, implements On-Demand Digital Pathology® for research and training, as the adoption of digital pathology workflows increases OptraSCAN today announced its first UK-based customer NHS Trust...